Fatal interstitial pneumonitis in a patient treated with pegylated interferon alpha-2b and ribavirin for hepatitis C infection

V. H. Fuhrmann, L. Kramer, E. Bauer, G. Tucek, G. Laferl, G. Dekan, P. Schenk (Vienna, Austria)

Source: Annual Congress 2003 - Interstitial lung diseases
Session: Interstitial lung diseases
Session type: Thematic Poster Session
Number: 400
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. H. Fuhrmann, L. Kramer, E. Bauer, G. Tucek, G. Laferl, G. Dekan, P. Schenk (Vienna, Austria). Fatal interstitial pneumonitis in a patient treated with pegylated interferon alpha-2b and ribavirin for hepatitis C infection. Eur Respir J 2003; 22: Suppl. 45, 400

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A case of acute interstitial pneumonia which developed during the interferon and ribavirin treatment for chronic hepatitis C
Source: Eur Respir J 2005; 26: Suppl. 49, 84s
Year: 2005

Successful hepatitis B treatment with lamivudine and interferon-alpha in a patient with cystic fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 617s
Year: 2004

Efficacy of nebulized recombinant human alpha-2b interferon in infants with bronchiolitis
Source: Annual Congress 2009 - Diagnosis and treatment of viral respiratory infections in early childhood
Year: 2009


Non-specific interstitial pneumonia of the pediatric age and recombinant interferon gamma-1b
Source: Eur Respir J 2004; 24: Suppl. 48, 717s
Year: 2004

Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis
Source: Eur Respir J 2006; 28: 496-504
Year: 2006



Successful treatment of severe respiratory papillomatosis with intravenous cidofovir and interferon α-2b
Source: Eur Respir J 2002; 20: Suppl. 38, 157s
Year: 2002

Fulminant hepatitis during antituberculosis chemotherapy: five case reports
Source: Eur Respir J 2005; 26: Suppl. 49, 645s
Year: 2005

Sarcoidosis associated with interferon-α therapy for chronic hepatitis C
Source: Eur Respir J 2006; 28: Suppl. 50, 541s
Year: 2006

Successful treatment of severe respiratory papillomatosis with intravenous cidofovir and interferon α-2b
Source: Eur Respir J 2001; 17: 830-831
Year: 2001



Promoters and inhibitors m-RNAs expression before and after treatment with interferon gamma-1b or colchicine in idiopathic pulmonary fibrosis: preliminary results
Source: Eur Respir J 2003; 22: Suppl. 45, 83s
Year: 2003

Evolution of previous sarcoidosis under type 1 interferons given for severe associated disease
Source: Eur Respir J 2005; 25: 570-573
Year: 2005



Sarcoidosis related to interferon and ribavirin treatment of hepatitis C – Analysis of four cases
Source: International Congress 2014 – Sarcoidosis
Year: 2014

Severe hepatitis associated with sitaxentan and response to glucocorticoid therapy
Source: Eur Respir J 2009; 33: 1518-1519
Year: 2009


Azathioprine and low-dose prednisone in chronic pulmonary sarcoidosis
Source: Eur Respir J 2005; 26: Suppl. 49, 268s
Year: 2005

Evaluation of efficacy of interferon inducer in treatment of the recurrent acute respiratory viral infections in children
Source: Annual Congress 2012 - Fungal, viral and other infections
Year: 2012


Efficacy and toxicity of azathioprine plus corticosteroids in 32 patients with chronic persistent sarcoidosis
Source: Eur Respir J 2004; 24: Suppl. 48, 712s
Year: 2004

Treatment of Idiopathic pulmonary fibrosis with interferon beta - our experience in seven patients
Source: Eur Respir J 2003; 22: Suppl. 45, 44s
Year: 2003

The role of hepatitis C virus infections in idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 333s
Year: 2005

Interferon gamma (IFN?) pathway deficiency and severe NTM disease
Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease
Year: 2021


Combination treatment with nintedanib and prednisolone for patients with idiopathic pulmonary fibrosis
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018